Share chart Akari Therapeutics, Plc
Extended chart
Simple chart
About Akari Therapeutics, Plc
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. more details| IPO date | 2015-09-21 |
|---|---|
| ISIN | US00972G1085 |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.akaritx.com |
| Цена ао | 1.31 |
| Change price per day: | -2.31% (1.3) |
|---|---|
| Change price per week: | -16.99% (1.53) |
| Change price per month: | +38.03% (0.9201) |
| Change price per 3 month: | +31.17% (0.9682) |
| Change price per half year: | -56.95% (2.95) |
| Change price per year: | -31.9% (1.865) |
| Change price per 3 year: | +5.83% (1.2) |
| Change price per 5 year: | -32.8% (1.89) |
| Change price per year to date: | +27.01% (0.9999) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Sabby Management, LLC | 164026 | 2.07 |
| Omnia Family Wealth, LLC | 87628 | 1.11 |
| Cerity Partners LLC | 23643 | 0.3 |
| Renaissance Technologies, LLC | 10269 | 0.13 |
| Bank of America Corporation | 150 | 0 |
| Truvestments Capital, LLC | 50 | 0 |
| Morgan Stanley | 8 | 0 |
| Tower Research Capital LLC (TRC) | 7 | 0 |
| Cornerstone Planning Group LLC | 5 | 0 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Ms. Wendy F. DiCicco CPA | Interim Chief Financial Officer | 540.34k | 1967 (58 years) |
| Dr. Miles Nunn | Chief Scientific Officer | N/A | 1969 (56 years) |
| Dr. Samir Rashmikant Patel M.D. | Interim President, CEO & Director | 3.7k | 1969 (56 years) |
Address: United Kingdom, London WG RT, 75/76 Wimpole Street - open in Google maps, open in Yandex maps
Website: https://www.akaritx.com
Website: https://www.akaritx.com
